trial

Supported Employment and Skills Training in Conjunction With Pharmacotherapy in Schizophrenia Patients

NCTId NCT00183625
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Completed
Enrollment 107 (actual)
Sponsored by University of California Riverside at C.I. Trials, Inc.-Inland Empire
Primary completion 2005-06
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Completed
Enrollment
107 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2000-06
Primary completion
2005-06
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
Individual Placement and Support (Supported Employment)Social Skills TrainingOlanzapineRisperidone

Sponsors

University of California Riverside at C.I. Trials, Inc.-Inland EmpireLead Sponsor
National Institute of Mental Health (NIMH)Collaborator
US Department of Veterans AffairsCollaborator

Investigators

1
Stephen R. Marder, MDPrincipal Investigator

Sites

2 total
Los Angeles, United StatesManchester, United States

Facts & assertions

4 sourced
Enrollment
107
Phase
PHASE4
Primary Completion Date
2005-06
Status
COMPLETED
relationships
The graph out of here
drug
Individual Placement and Support (Supported Employment)
drug
Social Skills Training
drug
Olanzapine
drug
Risperidone
drug
lead_sponsor
University of California Riverside at C.I. Trials, Inc.-Inland Empire
company
collaborator
National Institute of Mental Health (NIMH)
company
US Department of Veterans Affairs
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Stephen R. Marder, MD
person